The 4^th International Conference on Antibiotics: R&D, B2B , held from April 20-21, 2018, in Las Vegas, Nevada, USA, was a monumental event that brought together research experts, professors, research professionals, and policymakers from around the globe. This year's conference focused on the theme "Antibiotics Research: Current challenges and perspectives" aiming to address contemporary challenges by sharing cutting-edge research and best practices.

Opening Ceremony

Antibiotics Summit 2018  began with an inspiring opening ceremony. The Chair of the Organizing Committee welcomed the attendees and emphasized the importance of advanced techniques. The keynote address was delivered by the most eminent researchers, who highlighted the transformative potential of emerging technologies...

Scientific Sessions and Workshops

Antibiotics Summit 2018 featured a series of scientific sessions and workshops, where participants could delve deeper into specific topics and engage in interactive discussions. Key sessions included:

Call all conference sessions, EX: Session-1, Session-2, Session-3 and many more..!!!

Poster Presentations

The poster sessions were an integral part of Antibiotics Summit 2018, showcasing innovative research conducted by emerging scientists and research professionals. Over 50 posters were presented, covering a wide range of topics. The interactive nature of the poster sessions allowed for fruitful exchanges of ideas and networking opportunities.

Awards and Recognitions

Antibiotics Summit 2018 recognized outstanding contributing various awards, like The "Best Poster Presentation" award and The "Young Researcher" award.

Closing Ceremony

Antibiotics Summit 2018 concluded with a summary of key takeaways and future directions in pediatric care. We thanked the attendees for their participation and encouraged continued collaboration and innovation. The next Antibiotics Summit 2018 is promising to build on the success of this year's event and continue the tradition of excellence in innovative technologies.